149 related articles for article (PubMed ID: 11077032)
1. Nephrotoxicity of intravenous immunoglobulin.
Levy JB; Pusey CD
QJM; 2000 Nov; 93(11):751-5. PubMed ID: 11077032
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin and the kidney--a two-edged sword.
Orbach H; Tishler M; Shoenfeld Y
Semin Arthritis Rheum; 2004 Dec; 34(3):593-601. PubMed ID: 15609263
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk.
Dantal J
Am J Nephrol; 2013; 38(4):275-84. PubMed ID: 24051350
[TBL] [Abstract][Full Text] [Related]
4. Acute renal failure after large doses of intravenous immune globulin.
Haskin JA; Warner DJ; Blank DU
Ann Pharmacother; 1999; 33(7-8):800-3. PubMed ID: 10466908
[TBL] [Abstract][Full Text] [Related]
5. Acute renal failure resulting from intravenous immunoglobulin therapy.
Wajanaponsan N; Cheng SF
Hawaii Med J; 2004 Sep; 63(9):266-7. PubMed ID: 15540524
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin-associated acute renal failure: case series and literature review.
Itkin YM; Trujillo TC
Pharmacotherapy; 2005 Jun; 25(6):886-92. PubMed ID: 15927908
[TBL] [Abstract][Full Text] [Related]
7. Acute kidney injury due to sucrose-containing intravenous immunoglobulins.
Siddiqui W; Al Lawati S; Shaheen Faissal AM; Hannawi S; Al Riyami M; Al Salmi I
Saudi J Kidney Dis Transpl; 2019; 30(3):732-737. PubMed ID: 31249243
[TBL] [Abstract][Full Text] [Related]
8. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.
Daphnis E; Stylianou K; Alexandrakis M; Xylouri I; Vardaki E; Stratigis S; Kyriazis J
Nephron Clin Pract; 2007; 106(4):c143-8. PubMed ID: 17596722
[TBL] [Abstract][Full Text] [Related]
9. [Acute renal failure following treatment with intravenously administered immunoglobulins].
van Zanten AR; Beekhuyzen M; van der Meer YG; de Gooijer A; Feith GW
Ned Tijdschr Geneeskd; 2003 Feb; 147(7):307-10. PubMed ID: 12622009
[TBL] [Abstract][Full Text] [Related]
10. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
[TBL] [Abstract][Full Text] [Related]
11. Acute renal failure and intravenous immune globulin: sucrose nephropathy in disguise?
Perazella MA; Cayco AV
Am J Ther; 1998 Nov; 5(6):399-403. PubMed ID: 10099084
[TBL] [Abstract][Full Text] [Related]
12. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study.
Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):314-9. PubMed ID: 21953992
[TBL] [Abstract][Full Text] [Related]
13. Intravenous gammaglobulin-associated renal impairment reported to the FDA: 2004 - 2009.
Lin RY; Rodriguez-Baez G; Bhargave GA; Lin H
Clin Nephrol; 2011 Nov; 76(5):365-72. PubMed ID: 22000556
[TBL] [Abstract][Full Text] [Related]
14. Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy.
Zhang R; Szerlip HM
South Med J; 2000 Sep; 93(9):901-4. PubMed ID: 11005352
[TBL] [Abstract][Full Text] [Related]
15. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.
Chapman SA; Gilkerson KL; Davin TD; Pritzker MR
Ann Pharmacother; 2004 Dec; 38(12):2059-67. PubMed ID: 15536143
[TBL] [Abstract][Full Text] [Related]
16. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
[TBL] [Abstract][Full Text] [Related]
17. Renal safety of high-dose, sucrose-free intravenous immunoglobulin in kidney transplant recipients: an observational study.
Luque Y; Anglicheau D; Rabant M; El Karoui K; Jamme M; Aubert O; Clément R; Noël LH; Bollée G; Brodin-Sartorius A; Martinie M; Kreis H; Timsit MO; Legendre C
Transpl Int; 2016 Nov; 29(11):1205-1215. PubMed ID: 27529401
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy.
Ahsan N
J Nephrol; 1998; 11(3):157-61. PubMed ID: 9650125
[TBL] [Abstract][Full Text] [Related]
19. Acute renal transplant injury and interaction between antithymocyte globulin and pooled human immunoglobulin.
Gallay BJ; Perez RV; Ramsamooj R
Clin Transplant; 2004 Jun; 18(3):327-31. PubMed ID: 15142056
[TBL] [Abstract][Full Text] [Related]
20. Acute renal failure in acquired haemophilia following the use of high dose intravenous immunoglobulin.
Laidlaw S; Bainton R; Wilkie M; Makris M
Haemophilia; 1999 Jul; 5(4):270-2. PubMed ID: 10469182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
